Skip to content
TriangleGet started
← Full study record

NCT01876511 · FLOW

Participant flow

Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors (Cohorts A, B and C) · Source last updated 2020-02-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    MK-3475: MK-3475 10 mg/kg every 14 days
    id
    FG000
    title
    Cohort A: MSI Positive Colorectal Cancer
  2. description
    MK-3475: MK-3475 10 mg/kg every 14 days
    id
    FG001
    title
    Cohort B: MSI Negative Colorectal Cancer
  3. description
    MK-3475: MK-3475 10 mg/kg every 14 days
    id
    FG002
    title
    Cohort C: MSI Positive Non-Colorectal Cancer
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        11
      2. group Id
        FG001
        num Subjects
        24
      3. group Id
        FG002
        num Subjects
        16
      type
      Disease Progression-clinical/radiologic
    2. reasons
      1. group Id
        FG000
        num Subjects
        3
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        2
      type
      Death (unrelated)
    3. reasons
      1. group Id
        FG000
        num Subjects
        5
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        6
      type
      Drug-related Toxicity
    4. reasons
      1. group Id
        FG000
        num Subjects
        3
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        6
      type
      Patient Decision
    5. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      type
      Physician Decision
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        41
      2. group Id
        FG001
        num Subjects
        25
      3. group Id
        FG002
        num Subjects
        47
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        24
      2. group Id
        FG001
        num Subjects
        25
      3. group Id
        FG002
        num Subjects
        21
      type
      Stages 1 and 2
    3. achievements
      1. group Id
        FG000
        num Subjects
        18
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        16
      type
      COMPLETED
    4. achievements
      1. group Id
        FG000
        num Subjects
        23
      2. group Id
        FG001
        num Subjects
        25
      3. group Id
        FG002
        num Subjects
        31
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    MK-3475: MK-3475 10 mg/kg every 14 days
    id
    FG000
    title
    Cohort A: MSI Positive Colorectal Cancer
  2. description
    MK-3475: MK-3475 10 mg/kg every 14 days
    id
    FG001
    title
    Cohort B: MSI Negative Colorectal Cancer
  3. description
    MK-3475: MK-3475 10 mg/kg every 14 days
    id
    FG002
    title
    Cohort C: MSI Positive Non-Colorectal Cancer
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        11
      2. group Id
        FG001
        num Subjects
        24
      3. group Id
        FG002
        num Subjects
        16
      type
      Disease Progression-clinical/radiologic
    2. reasons
      1. group Id
        FG000
        num Subjects
        3
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        2
      type
      Death (unrelated)
    3. reasons
      1. group Id
        FG000
        num Subjects
        5
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        6
      type
      Drug-related Toxicity
    4. reasons
      1. group Id
        FG000
        num Subjects
        3
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        6
      type
      Patient Decision
    5. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        1
      type
      Physician Decision
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        41
      2. group Id
        FG001
        num Subjects
        25
      3. group Id
        FG002
        num Subjects
        47
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        24
      2. group Id
        FG001
        num Subjects
        25
      3. group Id
        FG002
        num Subjects
        21
      type
      Stages 1 and 2
    3. achievements
      1. group Id
        FG000
        num Subjects
        18
      2. group Id
        FG001
        num Subjects
        0
      3. group Id
        FG002
        num Subjects
        16
      type
      COMPLETED
    4. achievements
      1. group Id
        FG000
        num Subjects
        23
      2. group Id
        FG001
        num Subjects
        25
      3. group Id
        FG002
        num Subjects
        31
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Independent clinical review pending · Not medical advice